MEP26708A - Pharmaceutical oral preparation of a compound having an antifungic activity, and preparation method - Google Patents

Pharmaceutical oral preparation of a compound having an antifungic activity, and preparation method

Info

Publication number
MEP26708A
MEP26708A MEP-267/08A MEP26708A MEP26708A ME P26708 A MEP26708 A ME P26708A ME P26708 A MEP26708 A ME P26708A ME P26708 A MEP26708 A ME P26708A
Authority
ME
Montenegro
Prior art keywords
coating
preparation
compound
inert
pharmaceutical oral
Prior art date
Application number
MEP-267/08A
Other languages
Bosnian (bs)
English (en)
Inventor
Darder Carlos Picornell
Original Assignee
Liconsa Liberacion Controlada De Sustancias Activas S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8304581&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MEP26708(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Liconsa Liberacion Controlada De Sustancias Activas S A filed Critical Liconsa Liberacion Controlada De Sustancias Activas S A
Publication of MEP26708A publication Critical patent/MEP26708A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
MEP-267/08A 1998-07-21 1999-07-20 Pharmaceutical oral preparation of a compound having an antifungic activity, and preparation method MEP26708A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES009801539A ES2157731B1 (es) 1998-07-21 1998-07-21 Preparacion farmaceutica oral de un compuesto de actividad antifungica y procedimiento para su preparacion.
PCT/ES1999/000230 WO2000004881A1 (es) 1998-07-21 1999-07-20 Preparacion farmaceutica oral de un compuesto de actividad antifungica y procedimiento para su preparacion

Publications (1)

Publication Number Publication Date
MEP26708A true MEP26708A (en) 2010-06-10

Family

ID=8304581

Family Applications (1)

Application Number Title Priority Date Filing Date
MEP-267/08A MEP26708A (en) 1998-07-21 1999-07-20 Pharmaceutical oral preparation of a compound having an antifungic activity, and preparation method

Country Status (30)

Country Link
US (1) US6737082B1 (de)
EP (1) EP1103252B1 (de)
JP (1) JP4190732B2 (de)
KR (1) KR100572135B1 (de)
AT (1) ATE234077T1 (de)
AU (1) AU750730B2 (de)
BG (1) BG65187B1 (de)
BR (1) BR9912300A (de)
CA (1) CA2337509C (de)
CZ (1) CZ291938B6 (de)
DE (1) DE69905905T2 (de)
DK (1) DK1103252T3 (de)
EE (1) EE04415B1 (de)
ES (2) ES2157731B1 (de)
HR (1) HRP20010128B1 (de)
HU (1) HU228895B1 (de)
IL (1) IL140910A (de)
ME (1) MEP26708A (de)
MX (1) MXPA01000681A (de)
NO (1) NO320054B1 (de)
NZ (1) NZ509886A (de)
PL (1) PL194740B1 (de)
PT (1) PT1103252E (de)
RS (1) RS50063B (de)
RU (1) RU2209628C2 (de)
SK (1) SK283279B6 (de)
TR (1) TR200100177T2 (de)
UA (1) UA64009C2 (de)
WO (1) WO2000004881A1 (de)
ZA (1) ZA200101293B (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997027764A1 (en) * 1996-01-31 1997-08-07 South Alabama Medical Science Foundation Food and vitamin preparations containing the natural isomer of reduced folates
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
CN1402629A (zh) 1999-12-23 2003-03-12 辉瑞产品公司 提供提高的药物浓度的药物组合物
FR2842736B1 (fr) 2002-07-26 2005-07-22 Flamel Tech Sa Formulation pharmaceutique orale sous forme d'une pluralite de microcapsules permettant la liberation prolongee de principe(s) actif(s) peu soluble(s)
US20040115287A1 (en) * 2002-12-17 2004-06-17 Lipocine, Inc. Hydrophobic active agent compositions and methods
DE60312635T3 (de) * 2003-01-14 2013-05-08 Cimex Pharma Ag Zusammensetzung in Form eines festen Dispersion enthaltend Itraconazol und ein hydrophilisches Polymer mit einer verbesserten Bioverfügbarkeit
SI1438961T2 (sl) * 2003-01-14 2014-12-31 Cimex Pharma Ag Bioekvivalenten sestavek itrakonazola, dispergiranega v hidrofilnem polimeru
FR2852607B1 (fr) * 2003-03-20 2006-07-14 Procede de fabrication de microspheres de sucre de petite taille, les microspheres susceptibles d'etre obtenues par ce procede et leurs applications
FR2857591B1 (fr) * 2003-07-17 2007-11-02 Ethypharm Sa Particules comprenant un principe actif sous forme de co-precipite
ES2667668T3 (es) 2003-07-17 2018-05-14 Janssen Sciences Ireland Uc Procedimiento para preparar partículas que contienen un antiviral
FR2883179B1 (fr) 2005-03-18 2009-04-17 Ethypharm Sa Comprime enrobe
CA2619889C (en) 2005-08-22 2020-05-05 The Johns Hopkins University Use of itraconazole and salts thereof for treating cancer
CN101283984B (zh) * 2007-04-12 2010-05-26 永胜药品工业股份有限公司 高生物使用率的经杀真菌剂和聚合物涂覆的核心微粒状物
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
JP2013521249A (ja) * 2010-03-05 2013-06-10 ビーエーエスエフ ソシエタス・ヨーロピア 融解物で被覆された医薬形態
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
US9498485B2 (en) 2014-08-28 2016-11-22 Lipocine Inc. Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
WO2016033549A2 (en) 2014-08-28 2016-03-03 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
MA40982A (fr) * 2014-11-19 2017-09-26 Biogen Ma Inc Formulation de bille pharmaceutique comprenant du fumarate de diméthyle
RU2017141029A (ru) * 2015-05-25 2019-06-25 Сан Фармасьютикал Индастриз Лимитед Фармацевтическая пероральная композиция изотретиноина для применения один раз в сутки
US20160361322A1 (en) 2015-06-15 2016-12-15 Lipocine Inc. Composition and method for oral delivery of androgen prodrugs
US10137111B2 (en) 2016-08-11 2018-11-27 Adamis Pharmaceuticals Corporation Drug compositions comprising an anti-parasitic and proton pump inhibitor
US11559530B2 (en) 2016-11-28 2023-01-24 Lipocine Inc. Oral testosterone undecanoate therapy
WO2019113493A1 (en) 2017-12-08 2019-06-13 Adamis Pharmaceuticals Corporation Drug compositions
CN112313289A (zh) * 2018-04-27 2021-02-02 凸版印刷株式会社 缓释性复合颗粒、缓释性复合颗粒的制造方法、干燥粉体、以及壁纸
WO2020018974A1 (en) 2018-07-20 2020-01-23 Lipocine Inc. Liver disease
EP4452232A1 (de) * 2021-12-22 2024-10-30 Palau Pharma, S.L.U. Multipartikuläre albaconazolzusammensetzung

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4218458A (en) * 1978-06-23 1980-08-19 Janssen Pharmaceutica, N.V. Heterocyclic derivatives of (4-aryloxy-methyl-1,3-dioxolan-2-yl)methyl-1H-imidazoles and 1H-1,2,4-triazoles
US4916134A (en) * 1987-03-25 1990-04-10 Janssen Pharmacuetica N.V. 4-[4-[4-[4-[[2-(2,4-difluorophenyl)-2-(1H-azolylmethyl)-1,3-dioxolan-4-yl]me]phenyl]-1-piperazinyl]phenyl]triazolones
IE61651B1 (en) * 1990-07-04 1994-11-16 Zambon Spa Programmed release oral solid pharmaceutical dosage form
PH30929A (en) * 1992-09-03 1997-12-23 Janssen Pharmaceutica Nv Beads having a core coated with an antifungal and a polymer.
PH31594A (en) * 1993-09-30 1998-11-03 Janssen Pharmaceutica Nv Oral formulations on an antifungal.
US5567441A (en) * 1995-03-24 1996-10-22 Andrx Pharmaceuticals Inc. Diltiazem controlled release formulation
WO1997044014A1 (en) * 1996-05-20 1997-11-27 Janssen Pharmaceutica N.V. Antifungal compositions with improved bioavailability
WO1998007429A2 (en) * 1996-05-24 1998-02-26 Schering Corporation Antifungal composition with enhanced bioavailability
PL330864A1 (en) * 1996-06-28 1999-06-07 Schering Corp Orally administered composition containing antimycotic compounds of triazole
DE19626924C2 (de) * 1996-07-04 1999-08-19 Epazon B V Gerät zur Bereitstellung eines Atemgases
SK284813B6 (sk) * 1997-03-26 2005-12-01 Janssen Pharmaceutica N. V. Peleta obsahujúca itrakonazol, spôsob jej prípravy a farmaceutická dávková forma s jej obsahom

Also Published As

Publication number Publication date
ZA200101293B (en) 2001-08-21
HRP20010128B1 (en) 2003-12-31
HRP20010128A2 (en) 2002-12-31
YU3901A (sh) 2003-08-29
WO2000004881A1 (es) 2000-02-03
IL140910A0 (en) 2002-02-10
AU750730B2 (en) 2002-07-25
RS50063B (sr) 2009-01-22
DE69905905T2 (de) 2004-03-04
AU4782199A (en) 2000-02-14
EP1103252A1 (de) 2001-05-30
SK283279B6 (sk) 2003-05-02
NZ509886A (en) 2002-09-27
JP4190732B2 (ja) 2008-12-03
DK1103252T3 (da) 2003-07-14
ES2157731A1 (es) 2001-08-16
PL194740B1 (pl) 2007-06-29
EE200100041A (et) 2002-06-17
CA2337509C (en) 2005-12-27
RU2209628C2 (ru) 2003-08-10
BG65187B1 (bg) 2007-06-29
NO20010289D0 (no) 2001-01-17
SK862001A3 (en) 2001-08-06
HK1037531A1 (en) 2002-02-15
NO20010289L (no) 2001-03-07
EE04415B1 (et) 2005-02-15
ATE234077T1 (de) 2003-03-15
CZ291938B6 (cs) 2003-06-18
HU228895B1 (en) 2013-06-28
PL345625A1 (en) 2002-01-02
JP2002521323A (ja) 2002-07-16
BG105282A (en) 2001-11-30
KR100572135B1 (ko) 2006-04-19
PT1103252E (pt) 2003-07-31
UA64009C2 (en) 2004-02-16
MXPA01000681A (es) 2002-04-24
IL140910A (en) 2004-03-28
BR9912300A (pt) 2001-04-17
US6737082B1 (en) 2004-05-18
NO320054B1 (no) 2005-10-17
KR20010070990A (ko) 2001-07-28
CA2337509A1 (en) 2000-02-03
EP1103252B1 (de) 2003-03-12
HUP0103708A3 (en) 2002-07-29
ES2194480T3 (es) 2003-11-16
DE69905905D1 (de) 2003-04-17
ES2157731B1 (es) 2002-05-01
HUP0103708A2 (hu) 2002-02-28
TR200100177T2 (tr) 2001-07-23
CZ2001175A3 (en) 2001-05-16

Similar Documents

Publication Publication Date Title
MEP26708A (en) Pharmaceutical oral preparation of a compound having an antifungic activity, and preparation method
DK0868912T3 (da) Anvendelse af redispergerbare polymerpulvere eller polymergranulater til coating af farmaceutiske eller agrokemiske applikationsformer
EA200300999A1 (ru) Хронотерапевтические дозированные формы
DK1059848T3 (da) Dragéret tyggegummi, fremgangsmåde til fremstilling hraf samt anvendelse af et eller flere aktive stoffer i fast form
ATE412437T1 (de) Silber enthaltende zusammensetzungen, geräte und verfahren zu deren herstellung
DK2332523T3 (da) Ensartede film til hurtigtopløsende doseringsform indeholdende smagsmaskerende præparater
CA2044398A1 (en) Programmed release oral solid pharmaceutical dosage form
DE69510333D1 (de) Synergetische termitizide zusammensetzung aus pyrethroid und n-phenyl-pyrazol
JP2003512395A5 (de)
WO2004012699A3 (en) Modified release composition comprising coated micro matrix particles containing the high soluble active ingredient and a release controlling agent
NZ515230A (en) Fast-dispersing dosage forms containing fish gelatin
DK1124539T3 (da) Farmaceutisk formulering der omfatter omeprazol
IS2856B (is) Lyfjablanda úr ómeprasól
RU2001104894A (ru) Пероральная фармацевтическая композиция на основе соединения, имеющего антигрибковую активность, и способ ее получения
NO20033305D0 (no) Nytt filmbelegg
DK1333812T3 (da) Mikrogranulat baseret på aktivt stof og fremgangsmåde til at fremstille samme
EP1177788A3 (de) Fluoxetin-Arzneimittel in Form überzogener dispergierbarer Tabletten sowie Verfahren zu dessen Herstellung
ES2108619A1 (es) Composicion insecticida/acaricida.
DE60042972D1 (de) Trimetazidine enthaltendes Arzneimittel mit verzögerter Wirkstoffabgabe und Verfahren zur Herstellung
FI101855B1 (fi) Menetelmä asetatsolamidia jatkuvasti vapauttavan asetatsolamidivalmisteen valmistamiseksi
JPS5215819A (en) Gramineae weeds controlling agent
GT199700057A (es) Compuestos de dihalopropeno, agentes insecticidas / acaricidas que contienen los mismos, y productos intermedios parasuproduccion